Cancer BiologyCellsPeer-reviewed
Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival
Sławomir Andrzejewski, Marie Winter, Leandro Encarnação Garcia…·Eugen Dhimolea
This study identifies OXPHOS-high quiescent triple-negative breast cancer cells that survive chemotherapy and depend on BCL-XL for survival, showing that targeting BCL-XL enhances chemotherapy efficacy.
4 citations